Search  in | Advanced
   Print  
Statements


IN THIS SECTION
Archive
 

This section contains statements that have been released by AABB, its task forces or the entire blood community on issues relating to transfusion medicine and cellular therapies. Click on a link below to read current statements. For access to past statements, check our archive.


AABB Statement on XMRV Task Force – 2/17/10
Statement Before BPAC on Blood Pressure and Pulse as Blood Donor Eligibility Criteria – 11/17/09 (PDF)
Statement Before BPAC on Blood Donor Deferral for Malaria Risk Associated With Travel to Mexico – 11/16/09 (PDF)
Statement Before ACBSA on Decision Making Process for Transfusion and Transplantation Safety Policies – 5/1/09
Statement Before ACBSA on U.S. Biovigilance: Efforts to Bridge a Critical Donor and Patient Safety Gap – 4/30/09
Joint Statement Before BPAC on HBV NAT Using Triplex Assay Systems – 4/1/09
Joint Statement Before BPAC on Potential Testing Strategies for T. cruzi Infection in Blood Donors – 4/1/09
Presentation Before BPAC by the AABB Interorganizational Plasma Task Force – 4/2/09 (PDF)

Last modified on 2/18/2010 6:10:21 AM
What's New!
AABB Weekly Report - March 5, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details